Glaukos (NYSE: GKOS) net income
Glaukos reported a net loss of $187.7m for fiscal 2025; in fiscal 2024 it reported a net loss of $146.4m. Earnings per share were −$3.28.
Glaukos's best year of the last 10 was fiscal 2019. It reported a loss in 8 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$187.7m | — | −37.0% | −$3.28 |
| 2024 | −$146.4m | — | −38.2% | −$2.77 |
| 2023 | −$134.7m | — | −42.8% | −$2.78 |
| 2022 | −$99.2m | — | −35.1% | −$2.09 |
| 2021 | −$49.6m | — | −16.9% | −$1.07 |
| 2020 | −$120.3m | −880.3% | −53.5% | −$2.70 |
| 2019 | $15.4m | — | 6.5% | $0.41 |
| 2018 | −$13.0m | — | −7.1% | −$0.37 |
| 2017 | −$0.1m | −102.0% | −0.1% | $0.00 |
| 2016 | $4.5m | — | 4.0% | $0.14 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Glaukos net income compared with its sector
By net income for its latest fiscal year, Glaukos ranks 403rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Glaukos, −37.0%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 401st | Celcuity | −$177.0m | — |
| 402nd | Definium Therapeutics | −$183.8m | — |
| 403rd | Glaukos | −$187.7m | −37.0% |
| 404th | Allogene Therapeutics | −$190.9m | −7,341.8% |
| 405th | Sutro Biopharma | −$191.1m | −186.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Glaukos
- How much did Glaukos earn in fiscal 2025?
- Glaukos reported a net loss of $187.7m for fiscal 2025. In fiscal 2024 it reported a net loss of $146.4m.
- What are the earnings per share of Glaukos?
- They were −$3.28 in fiscal 2025, compared with −$2.77 in fiscal 2024.
- What was the most profitable year for Glaukos?
- Of its last 10 fiscal years, fiscal 2019, with $15.4m.
- Where does Glaukos rank in its sector by net income?
- It ranks 403rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Glaukos come from?
- From the annual report (Form 10-K) that Glaukos files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Glaukos files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Glaukos: the Glaukos page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.